Tdap Rec­om­mended For Preg­nant Women

Wellness Update - - Meet Our Doctors -

At­lanta, GA - The Ad­vi­sory Com­mit­tee for Im­mu­niza­tion Prac­tices voted 14 to 0, with one ab­sten­tion, to rec­om­mend providers of pre­na­tal care im­ple­ment a Tdap im­mu­niza­tion pro­gram for all preg­nant women. Health­care per­son­nel should ad­min­is­ter a dose of Tdap dur­ing each preg­nancy ir­re­spec­tive of the pa­tient’s prior his­tory of re­ceiv­ing Tdap. This builds upon a pre­vi­ous rec­om­men­da­tion made by ACIP in June 2011 to ad­min­is­ter Tdap dur­ing preg­nancy only to women who have not pre­vi­ously re­ceived Tdap. By get­ting Tdap dur­ing preg­nancy, ma­ter­nal per­tus­sis an­ti­bod­ies trans­fer to the new­born, likely pro­vid­ing pro­tec­tion against per­tus­sis in early life, be­fore the baby starts get­ting DTaP vac­cines. Tdap will also pro­tect the mother at time of de­liv­ery, mak­ing her less likely to trans­mit per­tus­sis to her in­fant. If not vac­ci­nated dur­ing preg­nancy, Tdap should be given im­me­di­ately post­par­tum, be­fore leav­ing the hospi­tal or birthing cen­ter. The U.S. re­mains on track to have the most re­ported per­tus­sis cases since 1959, with more than 32,000 cases al­ready re­ported along with 16 deaths, the ma­jor­ity of which are in in­fants.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.